Association of Fatigue and Outcomes in Advanced Cancer: An Analysis of Four SWOG Treatment Trials.
Julia MoAmy K DarkeKatherine A GuthrieJeff A SloanJoseph M UngerDawn L HershmanMark Allen O'RourkeMarie A BakitasRobert S KrousePublished in: JCO oncology practice (2021)
Oncology trial participants with baseline CSF had poorer survival and experienced more AEs than participants without CSF. This indicates fatigue as an important baseline prognostic factor in oncology treatment trials.